TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VISTAHVY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

VISTAHVY

ST13

US500000097880909

Class

5

Filing

97880909

Registration

7372991

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

12

Latest update

04/30/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

04/10/2023

Registration date

04/30/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/30/2024

Last transaction

04/30/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Stevenage, GB

Examiner

PATEL, SAMIR

Law office

L60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Glaxo Group Limited

Representatives

Elizabeth K. Rucki GSK

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Publications

History of USPTO decisions and trademark events.

12 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/13/2024

PUBO

PUBLISHED FOR OPPOSITION

02/13/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/24/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/05/2024

DOCK

ASSIGNED TO EXAMINER

01/05/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/12/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/12/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/12/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/04/2023

NWAP

NEW APPLICATION ENTERED

04/13/2023

Continuous trademark protection

Get notified about every new filing that threatens VISTAHVY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.